To The Top
Risk Factors for Thyroid Cancer, a Systematic Review
Presenter:

Terri Benskin

Date:

10-29-2020

Time:

4:00PM-4:30PM

Location:

Zoom

Thyroid cancer accounted for 1 out of every 20 female cancer diagnoses worldwide in 2018; the etiology of this disease is not well understood, and preventive programs are not established.  It is well known that thyroid cancer incidence has been increasing since the 1980s, largely attributed to the increase in diagnosis of papillary thyroid cancer and

Read More
FatPlants: A Comprehensive Website Platform of Plant Fat Related Genes, Proteins and Metabolism
Presenter:

Chunhui Xu

Date:

10-29-2020

Time:

3:30PM-4:30PM

Location:

Zoom

Increasing seed oil content by plant breeding has resulted in trade-offs or penalties with respect to protein content, seed size, or seed set. The molecular basis for this impasse is mostly speculative. Use of current global profiling approaches to better understand both the metabolic consequences of higher oil and the basis for reduced yield must

Read More
Cancer Surveillance Informatics – Missouri Cancer Registry and Research Center
Presenter:

Dr. Iris Zachary

Date:

10-22-2020

Time:

3:30pm-4:30pm

Location:

Zoom

Cancer surveillance has to be able to monitor trends of cancer cases, subtypes of cancer, and cancer clusters to inform cancer control and policies related to cancer and cancer care. The increasing complexity and depth of cancer care, treatment, and other elements to describe a cancer case require cancer registries to capture data from a

Read More
Development of A Blockchain Framework for Virtual Clinical Trials
Presenter:

Yan Zhuang

Date:

10-15-2020

Time:

4:00PM-4:30PM

Location:

Zoom

Clinical trials are essential for discovering new treatments, but there are multiple challenges to patient recruitment, patient engagement, and cost containment. Virtual clinical trials (VCT) are an innovative approach that provides potential solutions by conducting home-based, rather than site-based, clinical trials. Virtual clinical trials are still the exception rather than general practice due to technical

Read More
Identifying Patient-specific Flow of Signal Transduction Perturbed by Multiple Single-nucleotide Alterations
Presenter:

Olha Kholod

Date:

10-15-2020

Time:

3:30PM-4:00PM

Location:

Zoom

Background: Identifying patient-specific flow of signal transduction perturbed by multiple single-nucleotide alterations is critical for improving patient outcomes in cancer cases. However, accurate estimation of mutational effects at the pathway level for such patients remains an open problem. While probabilistic pathway topology methods are gaining interest among the scientific community, the overwhelming majority do not account

Read More

1 2 3 31